PHENERGAN 2.5 %, solution for injection 5 ampoules of 2 ml
Active ingredients: Promethazine hydrochloride, PROMÉTHAZINE
Commercialized according to BDPMDispensing in France: Prescription only
Solution for injection5 ampoules of 2 mlintramusculaire;intraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- PHENERGAN 2,5 POUR CENT, solution injectable
- Pharmaceutical form
- solution injectable
- Route of administration
- intramusculaire;intraveineuse
- Presentation description
- 5 ampoule(s) en verre de 2 ml
- Marketing authorisation holder
- LABORATOIRES FRILAB
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 19 Apr 1948
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
69646945CIP73082240CIP133400930822401Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| PROMÉTHAZINEsolution | 2,500 g · 100 ml de solution injectable | FT |
| CHLORHYDRATE DE PROMÉTHAZINEsolution | 2,820 g · 100 ml de solution injectable | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.